Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2020 | Radiosensitization in bladder cancer

Wassim Kassouf, FRCS, MD, McGill University Health Centre, Montreal, Canada, discusses the combination of radiation with immune checkpoint inhibition in bladder cancer. Prof. Kassouf goes on to discuss BL13 (NCT03768570), an open-label randomized trial investigating trimodality therapy with or without durvalumab to treat patients with muscle-invasive bladder cancer. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.